We advise you to exercise VanEck Vectors fundamental analysis to see if markets are presently mispricing the entity. In other words you can harness it to find out if VanEck Vectors Biotech is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found eleven available drivers for VanEck Vectors Biotech ETF which can be compared to its competition. Please use VanEck Vectors One Year Return and Net Asset to make a decision on weather VanEck Vectors Biotech is priced fairly. Use VanEck Vectors to protect against small markets fluctuations. The etf experiences normal downward trend and little activity. Check odds of VanEck Vectors to be traded at $124.72 in 30 days
VanEck Vectors Company SummaryVanEck Vectors competes with Financial Select, Technology Select, Vanguard Information, Energy Select, and HEALTHCARE SS. VanEck Vectors Biotech ETF is USA based ETF administrated by Van Eck Associates Corporation. The ETF is issued and managed by Van Eck, and composed of 26 constituents. The fund currently manages 560.2 M in total asset with 0.35 percent management fee and under 0. percent of total fund expense. VanEck Vectors Biotech ETF invests mostly in Developed Markets around Global and is publically traded since December 20, 2011.
VanEck Vectors One Year Return vs Price to Book
VanEck Vectors Biotech ETF is rated below average in one year return as compared to similar ETFs. It is fifth largest ETF in price to book as compared to similar ETFs fabricating about 8.84 of Price to Book per One Year Return.